InterSol
Active substance: SODIUM CHLORIDE, SODIUM ACETATE, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
SOLUTION · SODIUM CHLORIDE 452 mg/100mL, SODIUM ACETATE 442 mg/100mL, TRISODIUM CITRATE DIHYDRATE 318 mg/100mL, SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM 305 mg/100mL, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE 93 mg/100mL
United StatesActive
Marketing holder: Fenwal, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM CHLORIDE · 452 mg/100mL
- SODIUM ACETATE · 442 mg/100mL
- TRISODIUM CITRATE DIHYDRATE · 318 mg/100mL
- SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM · 305 mg/100mL
- SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE · 93 mg/100mL
Registration
- Registration number
- 0942-9601
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 0942-9601 · Verified 2026-10-09 · open in source